Intuitive announced that the FDA has cleared the da Vinci Single Port surgical system for use in inguinal hernia repair, cholecystectomy, and appendectomy procedures. These clearances expand da Vinci SP’s capabilities and build on its existing U.S. clearances in urology, colorectal, thoracic and transoral procedures.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ISRG:
- Intuitive Surgical: Buy Rating Backed by Innovative Imaging Technologies and Growth Potential
- China Flags Humanoid Robot Bubble Risk as Investor Hype Grows
- Intuitive Surgical: Strong Growth Potential and Strategic Positioning Drive Buy Rating
- Seaport biotech analysts hold an analyst/industry conference call
- Intuitive Surgical price target raised to $560 from $475 at Freedom Capital